Zonampanel, formerly known as YM-872, is an AMPA receptor antagonist potentially for the treatment of stroke. YM872, attenuates regional cerebral edema and IgG immunoreactivity following experimental brain injury in rats. YM872, attenuates cortical tissue loss, regional cerebral edema, and neurological motor deficits after experimental brain injury in rats. References: O'Hare Doig RL, Bartlett CA, Smith NM, Hodgetts SI, Dunlop SA, Hool L, Fitzgerald M. Specific combinations of Ca(2+) channel inhibitors reduce excessive Ca(2+) influx as a consequence of oxidative stress and increase neuronal and glial cell viability in vitro. Neuroscience. 2016 Oct 8. pii: S0306-4522(16)30514-0. doi: 10.1016/j.neuroscience.2016.10.005. PubMed PMID: 27725216.

纯度：≥98%

CAS：210245-80-0